PubMed · 2008 · 43 citations · 17 references
MedicineGeneticsOncologyCancer GeneticsMedical GeneticsMolecular OncologyCancer BiomarkersColorectal CancerMolecular Classification Of TumorsTumor MarkersColorectal Cancer PredispositionColorectal Cancer PrognosisDisease Prognostic BiomarkersGenetic PolymorphismsGenetic Prognostic MarkersMolecular Risk MarkersPrognostic BiomarkersTumor Stage Prognosis
BACKGROUND: Cancer of the colorectal region is the second most frequent cause of death among malignant diseases. The influence of two allelic polymorphisms of GSTM1 and GSTT1, and that of p53 gene codon 72 on colon cancer was investigated. PATIENTS AND METHODS: Intraoperatively removed tissue samples were processed from colorectal cancer patients. Cancer-free human samples were used as matched controls. Samples were digested with proteinase-K. DNA solution was used for PCR amplification. RESULTS: No significant difference was found between tumor patients and controls in the investigated polymorphisms. A significant association was found in Dukes' B stage patients between the GSTM1 and p53 gene variants and survival. In patients with GSTM1 null genotype and p53 Arg/Pro heterozygotes or Pro/Pro homozygotes the chance of survival is significantly lower than in the case of GSTM1+ and p53 Arg/Arg variants (p=0.009 and p=0.008, respectively). CONCLUSION: The significance of the investigated polymorphisms in prognosis is dependent on the tumor stage. These parameters might be used in certain cases as prognostic biomarkers in clinical diagnostics and in the planning of individual therapy.
17
The classification of cancer of the rectum
Cuthbert Dukes · The Journal of Pathology and Bacteriology · 1932 · 1.5K citations
Bengt Mannervik, Per Ålin, Claes Guthenberg et al. · Proceedings of the National Academy of Sciences · 1985 · 1.1K citations · Full text